STOCK TITAN

10,200 DTIL (NASDAQ: DTIL) shares slated for Rule 144 sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

DTIL received a Rule 144 notice for a planned sale of 10,200 shares of its common stock through Fidelity Brokerage Services LLC on 01/21/2026, to be sold on NASDAQ with an aggregate market value of $41,073.36. These shares were acquired from the issuer on 01/20/2026 through restricted stock vesting as compensation on the same date. The filing notes that the seller represents they are not aware of any material adverse, non-public information about the issuer’s current or prospective operations.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the DTIL Form 144 filing disclose?

The Form 144 for DTIL discloses a planned sale of 10,200 shares of common stock under Rule 144, to be sold on NASDAQ through Fidelity Brokerage Services LLC with an aggregate market value of $41,073.36.

How many DTIL shares are planned to be sold and at what value?

The notice covers 10,200 shares of DTIL common stock with an aggregate market value of $41,073.36, according to the filing’s securities information table.

When were the DTIL shares acquired and how?

The 10,200 common shares were acquired on 01/20/2026 via restricted stock vesting from the issuer, with the nature of payment listed as compensation on the same date.

When is the DTIL Rule 144 sale expected to occur?

The filing lists an approximate date of sale of 01/21/2026 for the planned sale of 10,200 DTIL common shares on NASDAQ.

How many DTIL shares are reported as outstanding in the Form 144?

The Form 144 lists 13,256,751 shares of DTIL common stock as outstanding in the securities information section.

What representation does the DTIL seller make in the Form 144?

The person for whose account the securities are to be sold represents that they do not know any material adverse information about DTIL’s current or prospective operations that has not been publicly disclosed.
Precision Biosciences

NASDAQ:DTIL

DTIL Rankings

DTIL Latest News

DTIL Latest SEC Filings

DTIL Stock Data

96.53M
22.56M
11.28%
44.24%
9.66%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
DURHAM